Anti-Tubercular Treatment in Chronic Kidney Disease
For CKD patients including those on hemodialysis, use the standard first-line regimen (isoniazid, rifampin, pyrazinamide, ethambutol) with specific dose adjustments for renally-cleared drugs, particularly reducing ethambutol and streptomycin dosing frequency to 2-3 times weekly while maintaining the milligram dose, and administering all medications after dialysis sessions. 1, 2
Core Treatment Regimen
- First-line drugs (isoniazid, rifampin, pyrazinamide) require no dose adjustment in renal failure as they are predominantly metabolized by the liver 3, 4
- The standard 6-month short-course regimen (2 months intensive phase with 4 drugs, followed by 4 months continuation phase) remains the foundation of treatment 2, 4
- Treatment duration and drug selection should follow standard TB guidelines, with modifications only for dosing frequency and timing 2
Critical Dose Adjustments for Renally-Cleared Drugs
Ethambutol
- Requires significant dose reduction due to exclusive renal excretion 3
- For creatinine clearance 50-100 mL/min: use 25 mg/kg body weight 3
- For creatinine clearance 30-50 mL/min: administer dose twice weekly 3
- For creatinine clearance 10-30 mL/min: use 15 mg/kg every 36-48 hours 3
- For hemodialysis patients: give 25 mg/kg 4-6 hours before dialysis 3
- Serum drug concentration monitoring is essential to avoid toxicity 3, 4
Streptomycin (if used)
- Reduce dosing frequency to 2-3 times weekly, but maintain the 12-15 mg/kg per dose to preserve concentration-dependent bactericidal effect 1
- For patients >59 years: reduce to 10 mg/kg per dose (750 mg maximum) 1
- Administer after dialysis to facilitate directly observed therapy and avoid premature drug removal 1
- Serum drug concentrations should not exceed 4 mg/L to avoid ototoxicity and nephrotoxicity 3
- Monitor closely as streptomycin carries increased risk of both ototoxicity and nephrotoxicity in renal impairment 1
Second-Line Injectable Agents (Amikacin, Kanamycin, Capreomycin)
- Apply same dosing principles as streptomycin: reduce frequency to 2-3 times weekly while maintaining 12-15 mg/kg per dose 1
- For patients >59 years: reduce to 10 mg/kg per dose (750 mg maximum) 1
- Give after dialysis sessions 1
- Serum drug concentration monitoring mandatory to prevent toxicity 1
- These agents carry higher nephrotoxicity risk than streptomycin, requiring vigilant renal function monitoring 1
Timing of Drug Administration
- All anti-tubercular drugs should be administered after hemodialysis sessions 2, 5
- This timing facilitates directly observed therapy adherence 1
- Prevents premature drug removal by dialysis 1
- Applies even to drugs with minimal dialyzability 5
Monitoring Requirements
Baseline Assessment
- Measure renal function (creatinine clearance) before treatment initiation 1, 3
- For injectable agents: obtain audiogram, vestibular testing, Romberg testing, and serum creatinine 1
- Baseline liver function tests 2
During Treatment
- Monthly renal function assessments for patients on injectable agents 1
- Monthly questioning regarding auditory or vestibular symptoms 1
- Serum drug concentration monitoring for ethambutol, streptomycin, and other injectable agents 1, 3
- Repeat audiogram and vestibular testing if symptoms of eighth nerve toxicity develop 1
- For capreomycin: monitor serum potassium and magnesium at least monthly 1
Special Considerations
Ethionamide (Second-Line Agent)
- For creatinine clearance <30 mL/min or hemodialysis: reduce dose to 250-500 mg/day 1
- Standard dose is 500-750 mg/day for normal renal function 1
Treatment Outcomes
- Mortality is significantly higher in hemodialysis patients, particularly in the first 4 months of dialysis 6
- Delayed diagnosis correlates with increased mortality 6
- Early recognition and prompt treatment initiation are critical 6
- Overall mortality in hemodialysis patients with TB can reach 22%, but 78% achieve clinical cure with appropriate treatment 6
Common Pitfalls to Avoid
- Do not reduce the milligram dose of injectable agents—only reduce frequency while maintaining dose per administration to preserve bactericidal effect 1
- Do not give injectable agents before dialysis—this removes the drug prematurely 1
- Do not assume all anti-TB drugs require adjustment—isoniazid, rifampin, and pyrazinamide do not 3, 4
- Do not skip therapeutic drug monitoring for ethambutol and injectable agents in renal failure—toxicity risk is substantially elevated 1, 3
- Avoid streptomycin in pregnancy due to fetal ototoxicity risk 1